Baker Bros. Advisors as of Dec. 31, 2013
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 95 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharmacyclics | 13.0 | $922M | 8.7M | 105.78 | |
| Seattle Genetics | 11.7 | $827M | 21M | 39.89 | |
| Incyte Corporation (INCY) | 10.6 | $750M | 15M | 50.63 | |
| Synageva Biopharma | 9.4 | $665M | 10M | 64.72 | |
| ACADIA Pharmaceuticals (ACAD) | 7.0 | $499M | 20M | 24.99 | |
| Salix Pharmaceuticals Inc note 2.750% 5/1 | 6.1 | $432M | 219M | 1.97 | |
| Genomic Health | 5.6 | $400M | 14M | 29.27 | |
| Incyte Corp Ltd conv | 4.7 | $332M | 275M | 1.21 | |
| Incyte Corp Incy Cvt 144a 0.37 convert | 4.4 | $311M | 259M | 1.20 | |
| Incyte Genomics Notes 4.75% 10/1/2015 conv bonds | 3.3 | $233M | 40M | 5.76 | |
| XOMA CORP Common equity shares | 2.2 | $155M | 23M | 6.73 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $137M | 1.9M | 70.35 | |
| Auxilium Pharmaceuticals note | 1.4 | $97M | 87M | 1.11 | |
| Halozyme Therapeutics (HALO) | 1.3 | $94M | 6.3M | 14.99 | |
| Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.1 | $80M | 23M | 3.47 | |
| Gilead Sciences conv | 1.0 | $71M | 22M | 3.30 | |
| Vanda Pharmaceuticals (VNDA) | 0.8 | $60M | 4.8M | 12.41 | |
| Medivation Inc note 2.625% 4/0 | 0.8 | $58M | 40M | 1.46 | |
| Itmn 2 1/2 12/15/17 | 0.8 | $56M | 41M | 1.37 | |
| Cerus Corporation (CERS) | 0.8 | $55M | 8.5M | 6.45 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $51M | 6.7M | 7.60 | |
| Repros Therapeutics | 0.7 | $51M | 2.8M | 18.30 | |
| Questcor Pharmaceuticals | 0.6 | $42M | 776k | 54.45 | |
| Gilead Sciences (GILD) | 0.6 | $42M | 556k | 75.10 | |
| Anacor Pharmaceuticals In | 0.6 | $42M | 2.5M | 16.78 | |
| Mirati Therapeutics | 0.6 | $40M | 2.4M | 16.63 | |
| Aegerion Pharmaceuticals | 0.5 | $36M | 500k | 70.96 | |
| Arrowhead Research | 0.5 | $34M | 3.1M | 10.85 | |
| Clovis Oncology | 0.5 | $32M | 531k | 60.27 | |
| Derma Sciences | 0.4 | $28M | 2.6M | 10.82 | |
| Medivation | 0.4 | $25M | 398k | 63.82 | |
| Chelsea Therapeutics International | 0.4 | $26M | 5.8M | 4.44 | |
| Intercept Pharmaceuticals In | 0.3 | $25M | 363k | 68.28 | |
| Progenics Pharmaceuticals | 0.3 | $22M | 4.2M | 5.33 | |
| Slxp 1 1/2 03/15/19 | 0.3 | $22M | 15M | 1.49 | |
| Intermune cv 5.0% | 0.3 | $20M | 17M | 1.16 | |
| AVANIR Pharmaceuticals | 0.3 | $18M | 5.4M | 3.36 | |
| Dyax | 0.2 | $15M | 2.0M | 7.54 | |
| Idera Pharmaceuticals | 0.2 | $15M | 3.2M | 4.63 | |
| Synergy Pharmaceuticals | 0.2 | $15M | 2.6M | 5.63 | |
| Insmed (INSM) | 0.2 | $14M | 796k | 17.00 | |
| D Stemline Therapeutics | 0.2 | $13M | 675k | 19.60 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.2 | $13M | 13M | 1.06 | |
| Kythera Biopharmaceuticals I | 0.2 | $12M | 313k | 37.35 | |
| ISIS Pharmaceuticals | 0.1 | $9.8M | 247k | 39.84 | |
| Zogenix | 0.1 | $9.5M | 2.8M | 3.44 | |
| 32 Infinity Pharmaceuticals | 0.1 | $8.9M | 643k | 13.81 | |
| Prothena (PRTA) | 0.1 | $8.9M | 337k | 26.52 | |
| Qlt | 0.1 | $8.6M | 1.5M | 5.57 | |
| Threshold Pharmaceuticals | 0.1 | $8.7M | 1.9M | 4.67 | |
| Discovery Laboratories | 0.1 | $8.4M | 3.7M | 2.25 | |
| Tg Therapeutics (TGTX) | 0.1 | $8.6M | 2.2M | 3.90 | |
| Array BioPharma | 0.1 | $7.5M | 1.5M | 5.01 | |
| Omeros Corporation (OMER) | 0.1 | $6.9M | 608k | 11.29 | |
| Ambit Bioscience | 0.1 | $7.2M | 748k | 9.64 | |
| Osiris Therapeutics | 0.1 | $6.0M | 375k | 16.08 | |
| Novavax | 0.1 | $6.6M | 1.3M | 5.12 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $6.3M | 546k | 11.61 | |
| XenoPort | 0.1 | $5.9M | 1.0M | 5.75 | |
| Sangamo Biosciences (SGMO) | 0.1 | $5.9M | 424k | 13.89 | |
| Portola Pharmaceuticals | 0.1 | $5.8M | 224k | 25.75 | |
| Aerie Pharmaceuticals | 0.1 | $5.4M | 300k | 17.96 | |
| BioDelivery Sciences International | 0.1 | $5.0M | 846k | 5.89 | |
| INC Ventrus Biosciences | 0.1 | $4.6M | 1.2M | 3.82 | |
| Biota Pharmaceuticals | 0.1 | $4.7M | 1.1M | 4.19 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $4.9M | 206k | 23.95 | |
| Xencor (XNCR) | 0.1 | $5.0M | 550k | 9.14 | |
| Tekmira Pharmaceuticals Corporation | 0.1 | $4.0M | 500k | 7.97 | |
| Epizyme | 0.1 | $4.6M | 220k | 20.80 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $3.9M | 94k | 41.54 | |
| Ligand Pharmaceuticals | 0.1 | $3.9M | 73k | 52.60 | |
| Ophthotech | 0.1 | $3.3M | 103k | 32.35 | |
| Synta Pharmaceuticals | 0.0 | $2.6M | 500k | 5.24 | |
| Puma Biotechnology (PBYI) | 0.0 | $2.6M | 25k | 103.52 | |
| Enanta Pharmaceuticals (ENTA) | 0.0 | $3.0M | 109k | 27.28 | |
| Receptos | 0.0 | $2.9M | 100k | 28.99 | |
| Macrogenics (MGNX) | 0.0 | $2.7M | 100k | 27.43 | |
| InterMune | 0.0 | $2.2M | 150k | 14.73 | |
| United Therapeutics Corporation (UTHR) | 0.0 | $2.3M | 20k | 113.10 | |
| Geron Corporation (GERN) | 0.0 | $1.9M | 403k | 4.74 | |
| Bluebird Bio (BLUE) | 0.0 | $2.4M | 115k | 20.98 | |
| Rigel Pharmaceuticals (RIGL) | 0.0 | $1.4M | 500k | 2.85 | |
| OraSure Technologies (OSUR) | 0.0 | $1.5M | 244k | 6.29 | |
| Amicus Therapeutics (FOLD) | 0.0 | $1.2M | 515k | 2.35 | |
| Achillion Pharmaceuticals | 0.0 | $1.5M | 455k | 3.32 | |
| ZIOPHARM Oncology | 0.0 | $1.1M | 254k | 4.34 | |
| Acceleron Pharma | 0.0 | $1.2M | 30k | 39.60 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $1.4M | 61k | 22.93 | |
| Galectin Therapeutics (GALT) | 0.0 | $813k | 101k | 8.08 | |
| Tesaro | 0.0 | $882k | 31k | 28.25 | |
| Foundation Medicine | 0.0 | $476k | 20k | 23.80 | |
| Salix Pharmaceuticals | 0.0 | $326k | 3.6k | 90.03 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $193k | 21k | 9.20 | |
| Chemocentryx | 0.0 | $290k | 50k | 5.80 | |
| Five Prime Therapeutics | 0.0 | $333k | 20k | 16.80 |
